Search

The article discusses a rare iatrogenic complication involving external iliac vein injury and acute iliofemoral deep venous thrombosis after total hip arthroplasty. The case study describes successful endovascular repair in a 62-year-old female patient with comorbidities. The article highlights the importance of prompt detection and treatment of vascular injuries post-THA, emphasizing the benefits of endovascular techniques in complex cases. The successful use of a stent graft in this case demonstrates a less invasive alternative to open surgical repair, particularly in patients with high comorbidity. [Extracted from the article]

Objectives: In this study, perioperative properties and early outcomes of patients who underwent combined Temren rotational atherectomy (RA) and drug-coated balloon (DCB) angioplasty treatment for complex femoropopliteal lesions in a single center were reported. Methods: Between June 2019 and February 2020, 40 patients who underwent combined Temren RA and DCB treatment due to critical lower limb ischemia or claudication-limiting daily living activities were retrospectively evaluated. Results: The mean age of patients was 73.2 ± 7.8 years and the majority of the patients were male (65%). Of the patients, 17 had critical limb ischemia and 23 had lifestyle-limiting claudication. Pathologies were total occlusion in 33 limbs and critical stenosis in seven limbs. Nine patients previously underwent endovascular intervention or surgery. The mean total occlusion length was 140.9 ± 100.9 (range, 20–360) mm in patients with chronic total occlusion. There was an additional iliac artery pathology in 5 and below the knee pathology in 8 patients. Rotational atherectomy was possible in all cases. Flow-limiting dissection was seen in six patients (15%). Provisional stent was performed to these patients. Following Temren RA, all patients underwent DCB. Adequate vascular lumen (less than 30% stenosis) was provided in all patients and the symptoms regressed. No distal embolization was encountered. Access site complications (17.5%) were small hematoma in four patients, ecchymosis in two patients, and pseudoaneurysm of the femoral artery in one patient. The mean follow-up was 13.55 ± 4.2 (range, 1–18) months. Re-occlusion was seen in three patients (7.5%) (n = 2 at 2 months and n = 1 at 4 months). Of these patients, two had required open revascularization via femoropopliteal bypass graft with common, superficial femoral, and popliteal artery endarterectomy and one had required femoro-posterior tibial artery bypass. Four minor toe amputations (10%) were performed to reach complete wound healing in the critical limb ischemia patients. A below-knee amputation was performed in a 94-year-old patient with long segment stenosis at the end of a 1-month follow-up period. There was no mortality after follow-ups. The Kaplan–Meier estimator estimated the rate of freedom from target lesion revascularization (TLR) which was 92.3%. The decrease in the Rutherford levels after the procedure was found to be statistically significant in 36 patients (p < 0.001). The increase in the ankle–brachial index after the procedure was found to be statistically significant in 36 patients (p < 0.001). Conclusions: Combined use of Temren RA with adjunctive DCB is safe and effective method with high rates of primary patency and freedom from TLR and low rates of complication in the treatment of femoropopliteal lesions. [ABSTRACT FROM AUTHOR]

Objectives: In this study, we present our initial experience in the use of carbon dioxide (CO2) digital subtraction angiography (DSA) for the treatment of peripheral arterial disease. Patients and methods: This retrospective study included a total of six male patients (mean age 63.5±6.9 years; range, 56 to 72 years) with Rutherford Stage 3-4 who were high-risk for chronic renal failure and underwent percutaneous transluminal angioplasty (PTA) due to iliac or femoropopliteal lesions using CO2-DSA between October 2018 and January 2020. Demographic and clinical characteristics of the patients, ankle-brachial index (ABI) values, and technical success rate were evaluated. Results: No contrast medium was used in any of the procedure. Technical success rate was 100% and no intraoperative complication was observed. All patients had a non-significant increase in the creatinine levels during follow-up (p=0.076). There was a significant difference between the pre- and postoperative ABI values (p=0.028). All patients were followed in the wards after the procedure and were discharged on postoperative Day 1 with symptomatic recovery. Conclusion: Our study results show that CO2-DSA can be used as an affordable and effective alternative in the diagnosis and treatment of peripheral arterial disease with contraindications for iodinated contrast material. [ABSTRACT FROM AUTHOR]

Objectives: In this study, we present our early and mid-term experiences following treatment of femoropopliteal lesions via percutaneous transluminal angioplasty (PTA) in patients over 70 years of age. Patients and methods: This single-center, retrospective study included a total of 41 PTA procedures in 35 patients (23 males, 12 females; median age 74 years; range 70 to 87 years) due to femoropopliteal lesions between August 2015 and April 2018. The technical success rate was evaluated. The Kaplan-Meier analysis was used to evaluate the primary patency rate at 12 and 24 months. Results: The mean follow-up was 14.9±8.9 months. The technical success rate was 95.1%. The bailout stenting was required in 12 patients (29.3%). Only four patients (9.8%) required percutaneous reintervention at the end of the follow-up. The Kaplan-Meier analysis revealed primary patency rates as 82.9% and 57.2% at 12 and 24 months, respectively. Conclusion: Our study results support the idea that PTA in elderly patients with femoropopliteal lesions is a safe and effective option and can be applied with favorable results in the early and mid-term. In addition, endovascular procedures can be performed by cardiovascular surgeons with high success and low complication rates. [ABSTRACT FROM AUTHOR]

Copyright of Firat Tip Dergisi is the property of Firat University, Faculty of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: Mobbing is an act of psychological intimidation via an emotional attack, abusing the existing power or position among the workers in a workplace. The objective of this study is to scrutinize the frequency of mobbing in the workplace among working individuals, modes of mobbing behavior, characteristics of individuals who implement or face mobbing, the frequency of depression among individuals who face mobbing, and the relationship between mobbing and depression. Methods: One hundred individuals, who were at least high school graduates, participated in this study, which was conducted in descriptive and crosssectional order. The participants, selected via simple random sampling, have provided their demographic features, filled out a survey form on the frequency of psychological mobbing they faced during the last six months at the workplace and the Beck Depression Inventory. Results: A total of 100 individuals (67% females) were accepted in the study. 43% of the participants stated that they have faced mobbing and it was determined that depression was observed in the 98% of these cases. It was identified that both males and females were subjected to mobbing by their male superiors (79%). Mean mobbing score was 1.51±0.53 among individuals without depression; and it was 2.07±0.70 among those with a medium level of depression; and it was 2.58±0.7 among those with heavy depression. A significant correlation was found between Beck depression and mobbing scores (r: 0.464, p<0.001). Discussion: Mobbing in the work environment should be considered as a significant occupational health issue and necessary measures should immediately be taken to deal with it. [ABSTRACT FROM AUTHOR]

Background: This study aimed to examine the early clinical outcomes of AngioJet rheolytic thrombectomy (RT) in patients with acute bilateral iliofemoral deep vein thrombosis (IFDVT), with a specific focus on the incidence of post-thrombotic syndrome (PTS)., Methods: From March 2021 to August 2023, sixteen consecutive patients with acute bilateral IFDVT treated with AngioJet RT at our center were evaluated. Primary outcomes include patency of the target veins, development of PTS, recurrent DVT, and procedure related death. Secondary outcomes included minor or major bleeding, acute kidney injury (AKI), documented haemoglobinuria, cardiac event, pulmonary embolism, limb loss, and death., Results: The mean age of the patients was 69 ± 12 years (range, 53-87 years). Malignancy and recent major surgery were the most prevalent risk factors, each observed in 25% of patients (n=4). Technical success, complete clot removal, and alleviation of symptoms were achieved in all patients (n=16; 100%). In a quarter of the patients (n=4), transient hemoglobinuria was observed following the procedure. This complication resolved spontaneously after adequate fluid replenishment. Minor bleeding occurred in three patients (19%), while no patients had major bleeding complication. There was one postoperative AKI and transient bradycardia (6%). Three patients died after the procedures (19%). One patient (6%) developed postoperative massive PE. The mean follow-up was 11±6 months (range, 5-19 months). The primary patency rate was 92% and 91%, respectively, six and twelve months after procedures. One patient had reocclusion during the follow-up., Conclusions: AngioJet RT applied to patients with bilateral IFDVT provides a promising picture, providing a patent vein lumen with high procedural success and achieving convincing early symptomatic improvement in severely symptomatic patients with impaired quality of life. In this early case series, the feasibility of the AngioJet device in elderly cases appears to be a significant problem. Therefore, patient selection is essential., (Copyright © 2025. Published by Elsevier Inc.)

Objectives: Sarcopenia has been demonstrated to be related to unfavorable clinical outcomes in patients with vascular diseases. The purpose of this study is to evaluate the relationship between sarcopenia and clinical results in patients with peripheral arterial disease who underwent endovascular therapy (EVT)., Methods: This single-center retrospective study involved patients with PAD who underwent peripheral EVT at Ankara City Hospital, between January 2018 and December 2021. Two groups of patients were created: sarcopenic and non-sarcopenic patients according to computed tomography angiography muscle measurements. Primary outcome measures were major and minor amputation and survival. Mortality, amputation, and clinical characteristics were compared between the two patient groups. Hazard ratios (HRs) for amputation were calculated for each risk factor via univariate and multivariate analyses. Secondary outcomes included length of hospital stay and post-procedural complications., Results: The mean follow-up period was 29.9 ± 9 months for all patients. A total number of 100 patients (mean age 63.5 ± 9.2 years) were involved in the study cohort. A significant association was identified between mortality and sarcopenia ( p < .001 ). The mortality rate in the group with sarcopenia was significantly higher than the other group; 65.7% (23 patients) versus (20%, 13 patients) ( p < .001 ). The major amputation rate in the group with sarcopenia was 57.1%, the major amputation rate in the group without sarcopenia was calculated as 15.4%, revealing that the major amputation rate was detected to be significantly higher in the sarcopenia group ( p < .001 ). Multivariate regression analyses showed that only sarcopenia (HR, 0.52; 95% CI, 0.21-1.27; p = 0.15) was independently associated with major amputation in patients with PAD after EVT. Kaplan-Meier analysis revealed a statistically significant difference between the survival curves of sarcopenia and non-sarcopenia patients ( p < .001 )., Conclusions: Sarcopenia seems to be a possible risk factor associated with amputation in patients with PAD who undergo EVT. The results of this study imply that sarcopenia is a possible risk factor for overall survival in patients with PAD., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Blunt carotid artery injury can lead to impaired brain perfusion due to ischemic stroke and thromboembolic events. To reduce the risk of potential neurological complications, it is critical to determine the diagnosis and management protocol as quickly as possible after a detailed clinical examination. This report presents successful surgical treatment of a young male patient who developed a traumatic left common carotid artery thrombosis after a motor vehicle accident., Competing Interests: Conflicts of interest The author has no conflicts of interest to declare., (© 2022 The Korean Society of Traumatology.)

Objectives: The present study was aimed to evaluate the efficacy and early outcomes of n-butyl cyanoacrylate (NBCA) ablation in small saphenous vein (SSV) insufficiency., Methods: In this single-center, retrospective, single-arm study, NBCA ablation was performed in 80 patients with SSV insufficiency between September 2018 and May 2020. Primary outcomes (anatomic success rate and occlusion rate) and secondary outcomes (VCSS and AVVQ scores) of the patients were analyzed., Results: No technical failure and device-related complications were encountered. Anatomic success rate was 100% after procedures. Each treated SSV was occluded on colored Doppler ultrasonography immediately after the procedure, and all veins remained occluded at 2 weeks after the procedure. Partial recanalization was observed in five patients at 12-month follow-up. Kaplan-Meier analysis revealed an occlusion rates at 6 months and 12 months follow-up were 97.5% and 93.75%, respectively. The mean pretreatment VCSS (4.72 ± 2.04) decreased to 1.61 ± 0.93, 0.87 ± 0.58, and 0.73 ± 0.52 at 2 weeks, 6 months, and 12 months after treatment, respectively ( p < .001). The mean pretreatment AVVQ score (11.92 ± 2.23) decreased to 8.2 ± 1.89, 4.2 ± 1.16, and 3.32 ± 1.19 at 2 weeks, 6 months, and 12 months after treatment, respectively ( p < .001). The Clinical, Etiologic, Anatomic, and Pathophysiology clinical classification at 12 months demonstrated a significant reduction in disease severity compared with preoperative values ( p < .001). There was no mortality and major adverse events including anaphylaxis and pulmonary thromboembolism (PTE) related to procedure after follow-ups. Moreover, there were no symptoms or signs of any sural nerve injury and no cases of skin necrosis, infection, or hyperpigmentation. In addition, no hematoma, deep venous thrombosis, and hypersensitivity reactions were observed. Phlebitis-like abnormal reaction was observed in three patients (3.8%)., Conclusions: In conclusion, in patients with SSV insufficiency, NBCA ablation with VenaBlock® system appears to be an effective and reliable treatment method. At the 12-month follow-up, the NBCA of SSVs showed a low recanalization rate and had a satisfactory improvement on the VCSS and AVVQ scores.

Background: We present early and mid-term clinical outcomes of endovascular revascularization for femoropopliteal involvement of peripheral arterial disease., Methods: A total of 128 patients (113 males, 15 females; mean age: 63.4±9.9 years; range, 32 to 87 years) who underwent percutaneous transluminal angioplasty for femoropopliteal lesions between August 2016 and April 2018 were analyzed retrospectively. Treatment with Luminor® paclitaxel-coated drug-eluting balloon catheter or bailout therapy with iVolution® self-expanding nitinol stent were performed. Overall patency rates and freedom from reintervention rates were analyzed using the Kaplan-Meier analysis. The primary patency and freedom from reintervention to target lesion rates at 12 and 24 months were evaluated., Results: Technical success was achieved in 133 (93%) of the interventions with a median follow-up of 11 (range, 1 to 35) months. At 12 and 24 months, the mean overall patency rates were 85.6±3.7% and 66.8±6.7%, respectively and the mean freedom from reintervention to target lesion rates were 91.6±2.9% and 78.1±6.3%, respectively. The primary patency and freedom from reintervention to target lesion rates were significantly higher in the bailout stenting group than the drug-eluting balloon group at 12 months (97.3±2.7% vs. 94.8±6.1%, respectively, p=0.025 and 97.1±2.9% vs. 84.2±5.5%, respectively, p=0.005) and at 24 months (76.9±7.9% vs. 55.8±13.4%, respectively, p=0.025 and 85.2±7.0% vs. 70.2±13.6%, respectively, p=0.005)., Conclusion: Endovascular procedures including drug-eluting balloon and bailout stenting seem to be effective alternative treatment modalities for treatment of infrainguinal peripheral arterial disease and can be also used in patients with long lesions and/or total occlusion of femoropopliteal arteries., Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article., (Copyright © 2021, Turkish Society of Cardiovascular Surgery.)

Behçet's disease is a vasculitic pathology characterized by skin lesions, genital ulcers, aphthous stomatitis, and uveitis. Arterial aneurysms are rare in this disease. Herein, we report a rare case of an isolated brachial artery aneurysm with a history of Behçet's disease treated with endovascular covered stenting of the brachial artery., Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article., (Copyright © 2019, Turkish Society of Cardiovascular Surgery.)